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Self-administrationWe investigated the behavioral and molecular interactions between cocaine and nicotine, through evaluating
locomotor activity, nicotine intravenous self-administration and gene expression. Locomotor sensitization
was induced in male Wistar rats by repeated cocaine (20 mg/kg; i.p.) or saline injections once a day over
7 days. Three days after the last injection, rats were challenged with either saline or cocaine (15 mg/kg;
i.p.) and the locomotor activity was measured. The very next day animals received either saline or nicotine
(0.4 mg/kg; s.c.) and the locomotor cross-sensitization was tested. Animals were then prepared with
intrajugular catheters for nicotine self-administration. Nicotine self-administration patterns were evaluated
using ﬁxed or progressive ratio schedules of reinforcement and a 24-h unlimited access binge. Immediately
after the binge sessions animals were decapitated, the brains were removed and the nucleus accumbens
was dissected. The dynorphin (DYN), μ-opioid receptor (mu opioid), neuropeptide Y (NPY), brain-derived
neurotrophic factor (BDNF), tropomyosin-related tyrosine kinase B receptor (TrkB) and corticotropin-
releasing factor receptor type 1 (CRF-R1) gene expression were measured by the reverse transcription-
polymerase chain reaction (RT-PCR). Pretreatment with cocaine caused sensitization of cocaine motor re-
sponse and locomotor cross-sensitization with nicotine. In the self-administration experiments repeated
cocaine administration caused an increase in the nicotine break point and nicotine intake during a 24 h
binge session.
© 2013 Elsevier Inc. Open access under the Elsevier OA license. 1. Introduction
An important issue in the ﬁeld of drug abuse research is the char-
acterization of risk factors related to increased vulnerability to drug
addiction (Anthony and Petronis, 1995). There is growing clinical
evidence suggesting that previous exposure to cocaine increase the
vulnerability to nicotine addiction. Controlled human studies have
demonstrated that acute cocaine administration increases cigarette
smoking (Roll et al., 1996). Moreover, cocaine-dependent smokers
often report smoking more cigarettes during cocaine use (Budney et
al., 1993; Higgins et al., 1994; Torchalla et al., 2011).do de São Paulo (FAPESP —
ogy, School of Pharmaceutical
quara-Jaú Km 1, 14801-902,
fax: +55 16 3301 6980.
a).
vier OA license. Pre-clinical studies also provide evidences for cocaine-induced
increase in the vulnerability to nicotine abuse and addiction. For exam-
ple, in rhesus monkeys, higher rates of combined nicotine and cocaine
self-administration were observed, relative to isolated cocaine or nico-
tine self-administration (Freeman and Woolverton, 2009; Mello and
Newman, 2011).
In rats, several studies have demonstrated the effects of nicotine
exposure on cocaine self-administration (Horger et al., 1992; Anker
and Carroll, 2011). For example, it has been reported that nicotine
exposure increases the acquisition rates of cocaine self-administration
(Horger et al., 1992) and its break point under a progressive-ratio
(PR) schedule of reinforcement (Anker and Carroll, 2011).While, sever-
al studies have demonstrated the inﬂuence of nicotine exposure on
cocaine self-administration, the effect of previous exposure to cocaine
on nicotine self-administration has been poorly investigated.
Repeated nicotine administration may also lead to a sensitized
locomotor response following psychostimulant challenge (Santos et
al., 2009). This phenomenon is termed behavioral cross-sensitization.
Behavioral sensitization is suggested to reﬂect neuroadaptive processes
170 R.M. Leão et al. / Pharmacology, Biochemistry and Behavior 104 (2013) 169–176associated to drug addiction (Robinson and Berridge, 1993). Recently, it
was demonstrated that nicotine priming enhances cocaine-induced be-
havioral sensitization. However the effect of previous cocaine treatment
on nicotine-induced locomotor sensitization has not demonstrated yet.
Many studies indicate that neuroadaptations of themesocorticolimbic
dopamine system are related to drug abuse and addiction (Wise, 2009;
Pierce and Kumaresan, 2006; Nestler, 2001; Kalivas, 2007). In this way,
it has been demonstrated that repeated cocaine or nicotine exposure
produces many long-lasting alterations in the mesocorticolimbic sys-
tem that contribute to addiction-like behaviors (Cao et al., 2011; Koya
et al., 2009; Guez-Barber et al., 2011).
It has been proposed that cocaine and nicotine produce persistent
alterations in themesolimbic system due to changes in gene expression
(Russo et al, 2010; Dreyer, 2010). Studies suggest that administration
simultaneous of equipotent doses of nicotine and cocaine, produce
additive effects on nucleus accumbens dopamine release (Sziraki et
al., 1999; Gerasimov et al., 2000). However, change in gene expression,
associated with the effect of cocaine on increased vulnerability to nico-
tine addiction is still poorly understood.
Cocaine and nicotine modulate the release of neurotransmitters,
which activate their different receptors, leading to the activation of tran-
scription factors. Transcriptional activation in themesocorticolimbic sys-
tem has been associated to neural plasticity related to the development
of drug addiction (Chandrasekar and Dreyer, 2009).
Indeed, repeated cocaine or nicotine administrationmay change the
expression of neurotransmitters (e.g. dynorphine (DYN), neuropeptide
Y (NPY)), receptors (e.g. μ-opioid receptor, tropomyosin-related tyro-
sine kinase B receptor (TrkB) and corticotropin-releasing factor recep-
tor type 1 (CRF-R1)), and transcription factors (e.g. brain-derived
neurotrophic factor (BDNF)) (Ang et al., 2001; Ghitza et al., 2010;
Hope et al., 1994; Houdi et al., 1998; Kivinummi et al., 2011; Nestler,
2005a, 2005b, 2008; Shippenberg and Rea, 1997). These changes may
increase drug-seeking behavior.
Thus, the goal of the present study was to investigate the behavioral
and molecular changes that result from the interactions between co-
caine and nicotine. To this endwe evaluated whether the pretreatment
with cocaine could modify cocaine- or nicotine-induced locomotor ac-
tivity, nicotine intravenous self-administration, and the expression of
DYN, mu opioid, NPY, BDNF, TrkB and CRF-R1 genes.
2. Materials and methods
2.1. Subjects
Male Wistar rats, 225–250 g at arrival, obtained from the animal
breeding facility of the Univ. Estadual Paulista — UNESP were individu-
ally housed in plastic cages 19 cm (width)×30 cm (length) ×14 cm
(height).
Rats were continuously maintained on a reversed light cycle
(12-h:12-h, lights off at 08:00 a.m.) with controlled temperature
(21 °C) and humidity (35–40%), with unrestricted access to food
and water. During the experiment, rats received 18 g rat chow per
day provided in their home cage after each daily experimental
session. This feeding schedule results in the gradual weight gain of
approximately 15 g/week (Donny et al., 1995). Unlimited access to
water was available throughout all experiments. All experiments
were performed during the dark phase.
The experimental protocol was approved by the Ethics Committee
for Use of Human or Animal Subjects of the School of Pharmaceutical
Science — UNESP (CEP-19/2008).
2.2. Locomotor response to cocaine and nicotine
2.2.1. Apparatus
Locomotor activitymeasureswere conducted in commercially avail-
able (Columbus Instruments, Columbus, OH, USA) activity monitoringchambers, consisting of Plexiglas cages. The chambers, measuring
44 cm (width)×44 cm (length)×20 cm (height) cm included 10
pairs of photocells beams, which were used to measure the horizontal
locomotor activity. The consecutive interruption of two beams was
recorded as one locomotor count.
2.2.2. Locomotor measurement
Rats were pretreated with cocaine (20 mg/kg; i.p.) or saline for
7 days (Marin et al., 2008). Three days after the last cocaine (COC) or
saline (SAL) administration, rats were challenged with saline (COC–
SAL n=10; SAL–SAL n=10) or cocaine (15 mg/kg; i.p.) (COC–COC
n=10; SAL–COC n=10). Immediately following the injections,
animals were put in an activity chamber and their locomotor activity
was recorded during a 30-minute testing session as described above. In
the very next day the same animals received saline (COC–SAL n=10;
SAL–SAL n=10) or nicotine (NIC) (0.4 mg/kg; s.c.) (COC–NIC n=10;
SAL–NIC n=10). Immediately following the injections, animals were
put in an activity chamber and their locomotor activity was recorded
during a 15-minute testing session as described above. In both
tests, animals were allowed a 20-minute habituation period to the
photocell apparatus immediately prior to injections. Animals from
different groups were tested randomly during the dark phase
between 10:00 a.m. and 14:00 p.m.
2.3. Intravenous drug self-administration
Seven days after the locomotor test, animals were subjected to in-
travenous nicotine self-administration procedures. The general pro-
cedure was adapted from George et al. (2007).
2.3.1. Apparatus
For nicotine self-administration the animals were put individually
in Plexiglas experimental chambers (30×30.5×24.5 cm), enclosed in
light- and sound attenuating boxes. The ﬂoor of the chambers
consisted of a Plexiglas tray covered with sawdust. A hole in the ceil-
ing allowed the passage and free movement of the tethered catheter
(Strategic Applications Inc., Libertyville, IL, USA) that was connected
to a counterbalanced swivel and an infusion pump (Insight Equip-
ments®, Ribeirão Preto, SP, Brazil). The front wall of the chamber
contained one interchangeable panel. The panel was equipped with
two levers, located 5 cm from the ﬂoor, two cue lights (red and
green) above each lever and a session light in the middle of the
panel (12 cm from the ﬂoor).
2.3.2. Drug
(−) — Nicotine 99% was obtained from Sigma-Aldrich (St Louis,
MO, USA). The dose of nicotine was chosen based on previous exper-
iments conducted in our laboratory (Leão et al., 2012).
2.3.3. Training
Training consisted of three 60-minute training sessions, in which
each response on the active lever (alternated between left and right
sides) was reinforced with the delivery of 0.2 ml sucrose (6%) (ﬁxed
ratio schedule of reinforcement; FR 1), followed by a 10-second
time-out. Each rat was allowed continuous access to sucrose
solution during the entire 60-minute. Responding on the inactive
lever had no scheduled consequence.
2.3.4. Surgery
Twenty-four hours after the last training session, cocaine and sa-
line pretreated rats were implanted with permanently indwelling
catheters (Silastic™ silicon tubing, inner diameter=0.63 mm, outer
diameter=1.17 mm) into the right jugular vein under a combination
of ketamine (100.0 mg/kg) and xylazine (6.0 mg/kg) anesthesia. The
catheter was passed subcutaneously to the rat's back where it exited
through a small incision and was afﬁxed to a plastic pedestal
Table 1
Theprimer sequences used to amplify DYN,mu opioid, NPY, BDNF, TrkB andCRF-R1 genes.
Genes 5′-3′ sequence
CRFR1-For TTGGCAAACGTCCTGGGGTAT
CRFR1-Rev GCGGACAATGTTGAAGAGAAAG
BDNF-For TCACAGCGGCAGATAAAAAGACT
BDNF-Rev GTGTCTATCCTTATGAACCGCCAGCCAA
TrKb-For CCTCGTTGGAGAAGATCAAG
TrKb-Rev CGTGGTACTCCGTGTGATTG
Dyn-For CTCTCCAGCAGGTTTGGC
Dyn-Rev CTGGGACCGAGTCACCAC
Miopio-For TTACGGCCTGATGATCTTACGA
Miopio-Rev GGTGATCCTGCGCAGATTC
NPY-For GGGGCTGTGTGGACTGACCCT
NPY-Rev GATGTAGTGTCGCAGAGCGGAG
GAPDH-For ATGGGAAGCTGGTCATCAAC
GAPDH-Rev ACGCCAGTAGACTCCACGAC
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harness system (Strategic Applications Inc., Libertyville, IL, USA).
Rats were allowed to recover from surgery for 7 days in their home
cage with free access to food and water. To prevent inﬂammation
and infection rats received cetoprophen 1% (5.0 mg/kg; i.m.), and
cefazolin (10.0 mg/kg; i.v.) for three consecutive days following
surgery.
The catheter was ﬂushed daily with heparinized saline (20 IU/ml)
and 0.2 ml of saline in order to maintain the catheter's patency.
2.3.5. Nicotine self-administration
After recovering fromsurgery all ratswere initially givenunlimited ac-
cess to sucrose (6%) self-administration, in which each lever press was
reinforced with the delivery of 0.2 ml sucrose (6%) (ﬁxed ratio schedule
of reinforcement; FR 1), followed by a 10-second time-out. During
self-administration sessions, a green cue light above the active lever sig-
naled sucrose availability and a red cue light, also above the active lever,
signaled sucrose delivery. During the time-out period, the green and red
cue lights were extinguished and lever press were recorded but had no
consequences. Each daily session was terminated after 60-minute
of access. After three sessions of sucrose reinforcement nicotine
self-administration was assessed during 3-hour sessions. Initially,
nicotine (0.03 mg/kg per infusion) was infused (0.1 ml/s) associated to
sucrose 6% (0.2 ml, v.o.) delivered on schedule of reinforcement (FR1)
for the active lever. Responses on the inactive lever were recorded but
had no programmed consequence. Each daily session was terminated
after 10 drug infusions or 3-hour of access, whichever occurred ﬁrst.
Simultaneous administration of sucrose and nicotine sessions was
ended after completing 10 drug infusions within 3-hour over two
consecutive days. Following this period only nicotine (0.03 mg/kg per
infusion) was infused (0.1 ml/s) on schedule of reinforcement (FR1) for
the active lever. After completing 10 infusions of nicotine within 3-hour
over two consecutive days, the FR schedule was progressively increased
to ﬁxed ratio 3 (FR 3). Rats were maintained for at least four additional
days on a limited access on FR 3 schedule before being examined during
a progressive ratio schedule of reinforcement. The acquisition and main-
tenance took about 15 days.
2.3.6. Progressive ratio schedule of drug reinforcement
After the acquisition and maintenance phase, self-administration
according to a progressive ratio (PR) schedule of drug reinforcement
was veriﬁed. The progression of response requirements followed the
algorithm: 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26… The ﬁnal infu-
sion delivered was deﬁned as the break point. The PR session was ter-
minated once the rat failed to obtain an infusion during 60-minute. The
average number of total responses and the last ratio completed across
three PR trials for each individual rat was calculated.
2.3.7. Twenty-four hour unlimited access drug “binge”
After the ﬁnal PR session, each rat was allowed one additional day of
limited drug access (0.03 mg/kg per infusion of nicotine, FR3 schedule,
total of 10 infusions). The very next day, a 24-hour binge protocol
was implemented starting approximately at 10:00 a.m. Each rat was
allowed continuous access to drug infusions (0.03 mg/kg per infusion
— 0.1 ml/s) on FR1 schedule during the entire 24-hour binge. The
amounts of drug self-administered as well as the pattern of responding
were recorded.
2.4. Real time-polymerase chain reaction (RT-PCR)
Posterior, RT-PCR was used to determine changes of DYN, mu opi-
oid, NPY, BDNF TrKB and CRF-R1, twenty-four hour after the “binge”
session. Brieﬂy, animals were killed by rapid decapitation and the
nucleus accumbens was isolated, frozen in liquid nitrogen and stored
in -80C freezer for posterior RT-PCR assay. mRNA was extracted ho-
mogenizing individual samples in TRIzol® Reagent (Invitrogen, cat#15596-026) according to the manufacturer's instructions. Brieﬂy,
TRIzol® Reagent was added to each sample and the aqueous layer
was isolated following centrifugation. Total mRNA was precipitated
with isopropanol in the presence of linear acrylamide overnight. Sam-
ples were centrifuged and the extracted mRNA pellets were washed
with 70% ethanol and re-suspended in diethylpyrocarbonate water.
Total mRNA was quantiﬁed and its quality was examined through
the ratio 260/280 and the integrated of the bands was seen in gel of
agarose. Next the total mRNA was reverse-transcribed into cDNA
with random hexamers using Superscript III (Invitrogen, Carlsbad,
CA, USA). The primer sequences used to amplify DYN, mu opioid, NPY,
BDNF TrKB and CRF-R1, were listed in Table 1. Real-time RT-PCR was
performed in a total volume of 25 μl buffer solution containing 5 μl of
template cDNA, 12.5 μl 2× SYBR Green Master mix (Applied
Biosystems, Foster City, CA, USA), 1.5 μl MQ and 15 ρM of each primer.
The absolute cDNA quantities were determined, using standard curves,
with Applied Bioscience 7500 System Software. Cycle thresholds (Ct)
were calculated from triplicate reactions using the second derivative
of the ampliﬁcation curve. DYN, mu opioid, NPY, BDNF TrKB and
CRF-R1 Ct values were normalized to GAPDH Ct values (DCt) since
GAPDH was not regulated by cocaine/nicotine. Fold changes were cal-
culated using the DDCt method as described (Applied Biosystems,
Carlsbad, CA, USA).
2.5. Statistics
Data from the locomotor activity were analyzed by two-way
ANOVA for repeatedmeasure considering pretreatment (saline vs. co-
caine) and time after saline and cocaine or nicotine test injections as
the repeated factor. When a signiﬁcant (pb0.05) main effect was ob-
served F-tests for contrast analysis were applied.
Nicotine self-administration and gene expression data were ana-
lyzed using Student's t-tests comparing saline and cocaine groups.
Signiﬁcant differences are reported for pb0.05.
3. Results
3.1. Locomotor activity
3.1.1. Cocaine locomotor sensitization
Two-way ANOVA revealed signiﬁcant differences for pretreatment
[F(1,15)=4.91;pb0.05] and time after injection [F(1,15)=17.33;
pb0.001] factors. In addition, the interaction between factors was
also detected [F(1,15)=7.03; pb0.001].
Further analysis (F-Test) showed that rats pretreated with cocaine
showed signiﬁcantly higher cocaine–induced locomotor activity when
compared to the saline pretreated ones from 5 to 20 min after cocaine
injection (Fig. 1), evidencing that the pretreatmentwith cocaine caused
sensitization to its motor response (pb0.05).
Fig. 2. Locomotor activity following saline or cocaine (15 mg/kg; i.p.) challenge injec-
tions in rats pretreated with repeated cocaine (20 mg/kg; i.p.; daily during 7 days) or
saline administration. Rats were habituated in the activity-monitoring chamber for
20 min before the saline challenge injection. Data represent mean±SEM (N=10–11
animals per group) of locomotion counts accumulated in 5-minute intervals immedi-
ately after injections. * pb0.01 compared to rats pretreated with saline; ** pb0.05 com-
pared to rats pretreated with saline.
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Two-way ANOVA did not reveal signiﬁcant differences for the
pretreatment factor [F(1,15)=2.90; pb0.05]. However, ANOVA revealed
a main effect of time after injection [F(1,15)=5.56;pb0.05]. ANOVA did
show the interaction between factors [F(1,15)=2.13; pb0.05].
Further analysis (F-Test) showed that rats pretreated with cocaine
showed signiﬁcantly higher nicotine–induced locomotor activity
when compared to the saline pretreated ones in the ﬁrst 5 min
(Fig. 2), evidencing the cross-sensitization between cocaine and nico-
tine (pb0.05).
3.2. Nicotine self-administration
3.2.1. Progressive ratio schedule
Fig. 3 depicts the number of responses and the last ratio achieved
(break point) in a progressive ratio schedule to nicotine in animals
pretreated with cocaine or saline.
Student t-test revealed a signiﬁcant increase in the number of re-
sponses to obtain nicotine in the cocaine pretreated group when
compared to the saline pretreated one (t(15)=5.06;pb0.01). In addi-
tion, the last ratio achieved was higher in the cocaine group as com-
pared to the saline one (t(15)=5.32;pb0.001) (Fig. 3).
3.2.2. Twenty-four hour unlimited access nicotine (“binge”)
Fig. 4 depicts the number of responses, reinforcement and the total
nicotine intake during 24-hour “binge” session in cocaine or saline
pretreated animals.
Student t-test revealed a signiﬁcant increase in the number of re-
sponses (t(15)=2.19;pb0.05), reinforcements (t(15)=2.78;pb0.05),
and nicotine intake (t(15)=2.80;pb0.05), in the cocaine pretreated
rats when compared to the saline pretreated ones.
3.3. Real time-polymerase chain reaction
Fig. 5 depicts the quantitative RT-PCR of DYN,muopioid, NPY, BDNF,
TrKB and CRF-R1 twenty-four hours after the “binge” session.
Student t-tests revealed a signiﬁcant increase in BDNF expression in
the cocaine pretreated rats when compared to the saline pretreated
ones (t(11)=2.61;pb0.05). The expression of DYN, mu opioid, NPY,
TrkB or CRF-R1 was not signiﬁcantly modiﬁed by the pre-treatment
with cocaine.
4. Discussion
In the present study we evaluated whether the pretreatment with
cocaine could modify cocaine- or nicotine– induced locomotor activity,
nicotine intravenous self-administration, and the expression of DYN,
mu opioid, NPY, BDNF, TrkB and CRF-R1 genes (Fig. 6).
Repeated cocaine administration resulted in cocaine and nicotine lo-
comotor sensitization followed by an enhanced in nicotine break-point
and intake during a 24 h binge session. Furthermore, these alterations
in nicotine addiction-like behaviors were accompanied by a selective
increase in BDNF expression in the nucleus accumbens. Our results sug-
gest that previous cocaine exposure may increase the vulnerability to
nicotine addiction.Fig. 1. ExperimenIn rodents, depend on the dose, repeated exposure to drugs of
abuse may induce behavioral sensitization, that has been deﬁned as
a progressive and enduring enhancement of the motor stimulant ef-
fects of these drugs (Robinson and Berridge, 2000).
Our results are in accordance with other showing that repeated co-
caine injections cause locomotor sensitization (Brown et al., 2011;
Marin et al., 2008, 2009;Wuo-Silva et al., 2011). However, an important
ﬁnding of our study is the observation of cross-sensitization between
cocaine and nicotine. There are evidences that repeated nicotine injec-
tions increase the locomotor effects of cocaine. For instance, it has
been shown that adult and adolescent rats pre-treated with nicotine
displayed locomotor sensitization to psychostimulants, such as, cocaine
or amphetamine (Collins and Izenwasser, 2004; Santos et al., 2009).
However, Levine et al. (2011) showed in mice, that the pretreatment
with cocaine did not sensitize the locomotor response to nicotine. The
lack of consensus between our results and Levine's results may be due
to differences in the species used (rats vs. mice), and nicotine challenge
dose and route. To our knowledge, we have shown for the ﬁrst time that
the repeated pretreatment with cocaine causes cross-sensitization to
nicotine.
Considering that behavioral sensitization is thought to reﬂectmolec-
ular and cellular changes involved with the increase in the motivation
to drug self-administration (Robinson and Berridge, 2000, 2001, 2008;
Moussawi et al., 2009), we investigate whether repeated cocaine expo-
sure could also increase the motivation and self-administration.
We observed that previous repeated cocaine administration com-
bined with the nicotine self-administration caused an increase in
nicotine break point. Although nicotine self-administration in ro-
dents has been demonstrated in a number of laboratories (see Le
Foll and Goldberg, 2009 for review), to our knowledge this is the
ﬁrst study to demonstrate that repeated cocaine exposure increases
nicotine self-administration.
In our study, the PR schedule revealed a signiﬁcant increase in the
break-point in rats pretreated with cocaine relative to those pretreated
with saline, suggesting that they may be more motivated to obtaintal protocol.
Fig. 3. Locomotor activity following saline or nicotine (0.4 mg/kg; s.c.) challenge injec-
tions in rats pretreated with repeated cocaine (20 mg/kg) or saline administration.
Rats were habituated in the activity-monitoring chamber for 20 min before the saline
challenge injection. Data represent mean±SEM (N=10–11 animals per group) of loco-
motion counts accumulated in 5-minute intervals immediately after injections. * pb0.01
compared to rats pretreated with saline.
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demonstrated that previous exposure to nicotine increased the PR
response to cocaine self-administration (Bechtholt andMark, 2002). Al-
though tobacco is considered highly addictive in humans, in animal
models the reinforcing efﬁcacy of nicotine is weak (Robinson and
Pritchard, 1992). Thus our data, showing that cocaine-induced increase
in nicotine the PR schedule is quite relevant since they corroborate the
clinical hypothesis that cocaine intake is a risk factor for tobacco addic-
tion (Cousins et al., 2001).
Similarly, studies carried out in rhesus monkeys, showed that com-
bined self-administration of nicotine and cocaine was higher relative to
isolated cocaine or nicotine (Freeman andWoolverton, 2009;Mello and
Newman, 2011). This interaction has also been demonstrated to other
drugs, as previously reported by Henningﬁeld and Grifﬁths (1981).
These authors showed that the previous exposure to methylphenidate
increased nicotine-taking in a ﬁxed ratio schedule.Fig. 4. Number of responses (A) and the last ratio achieved (B) in a progressive ratio
schedule to nicotine in animals pretreated with repeated cocaine (20 mg/kg; i.p.; daily
during 7 days) or saline administration. Data represent mean±SEM (N=7–8 animals
per group). * pb0.05 compared to saline group.
Fig. 5. Number of responses (A), reinforcement (B) and the total nicotine intake (C) dur-
ing 24-hours “binge” session in animals pretreatedwith repeated cocaine (20 mg/kg; i.p.;
daily during 7 days) or saline administration. Data represent mean±SEM (N=7–8 ani-
mals per group). * pb0.05 compared to saline group.Weobserved that repeated cocaine treatment also caused escalation
of nicotine-taking behavior during a 24 h binge session, which was ac-
companied by persistent increase in lever pressing response. The 24-h/
day-access model is relevant, in special for nicotine self-administration,
because it is able to evaluate possible interferences of the circadian pat-
tern, which appears to be present in human smokers (Chandra et al.,
2007; Frederiksen and Frazier, 1977; Morgan et al., 1985).
This increase in nicotine intake could be due to cocaine withdrawal
symptoms, which could do the rats take more nicotine to relief these
symptoms. But more studies should be performed to address this issue.
Also, evidence has shown that previous nicotine administration
can increase the cocaine reward, measured by conditioned place pref-
erence (Levine et al., 2011). Taken together, these ﬁndings suggest
that the repeated exposure to these substances can promote similar
neuroadaptations in the brain reward pathway. Since, studies have
demonstrated that the capacity of drugs and other environmental
manipulations to promote increased sensitivity to drug's stimulant
effects and escalation of drug intake has been associated with
neuroadaptations in the dopaminergic mesolimbic system (Nestler,
2005a,b; Thomas et al., 2008). Repeated cocaine or nicotine exposure
can promote alterations on selected signaling cascades and growth
factors of excitatory transmission implicated in neuroplasticity un-
derlying addiction-related behaviors (Bhang et al., 2010; Malenka
and Bear, 2004; Muñoz et al., 2011; Poo, 2001; Sweatt, 2009).
Fig. 6. Quantitative RT-PCR of DYN, mu Opioid, NPY, BDNF, TrkB and CRF-R1 24 hour after the “binge” session, of the nucleus accumbens of rats pretreated with saline or cocaine.
Data represent mean±SEM (N=6 animals per group). * pb0.05 when compared to saline group.
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of addiction, craving and withdrawal (Grimm et al., 2003; Horger et
al., 1999; Pu et al., 2006). Evidences show an association between nic-
otine dependence and alterations in BDNF expression level (Andresen et
al., 2009; Bhang et al., 2010; Kenny et al., 2000).
Our results show a selective increase in the levels of BDNF mRNA
twenty-four hours after the end of the “binge” session in rats pretreated
with cocaine. These results suggest that pretreatment with cocaine on
its own or in combination of nicotine self-administration increased
BDNFmRNA levels in the nucleus accumbens. Indeed, it has been dem-
onstrated that contingent and noncontingent cocaine exposure increase
BDNFprotein levels in the striatum(Grahamet al., 2007; Liu et al., 2006;
Zhang et al., 2002). Moreover, it was demonstrated that repeated expo-
sure to cocaine produced long-lasting increase in BDNF levels in the nu-
cleus accumbens that is associated with enhanced responsiveness to
cocaine self-administration (Grimm et al., 2003). In addition, Richardson
and Roberts (1996) studies showed that injections of BDNF into the nu-
cleus accumbens increased rats' motivation to work for cocaine in a pro-
gressive ratio reinforcement schedule of cocaine self-administration.
Recently, a clinical study reported increased BDNF plasma levels in ab-
stinent smokers (Bhang et al., 2010). In animals, it was demonstrated
that repeated daily injections nicotine increased accumbal BDNF in ad-
olescent mice (Correll et al., 2009). Furthermore, Kivinummi et al.
(2011) showed that a chronic oral nicotine treatment, which promotes
increase in nicotine intake, promoted enhanced BDNF levels in the nu-
cleus accumbens.
Unfortunately, our experimental design makes difﬁcult to state
which manipulation could be mediating these alterations. Future
studies in our laboratory will speciﬁcally address this issue.
Although, studies have showed that BDNF-induced neural plastic-
ity is mediated by the TrkB receptor and that repeated cocaine admin-
istration increase TrKB expression (Crooks et al., 2010), we did not
ﬁnd up-regulation of this gene.Although we have not found changes in DYN, mu opioid, NPY, TrKB
and CRF-R1mRNA levels, other studies have demonstrated their involve-
ment in the behavioral effects of nicotine. For example, blockade of the
brain stress system using a corticotropin-releasing factor-1 (CRF1) recep-
tor antagonist decreases nicotine intake in rats (George et al., 2007). Sim-
ilarly, the antagonism of opioid neurotransmission by pretreatment with
naloxonazine, a mu opioid antagonist, signiﬁcantly reduced the number
of nicotine infusions during a self-administration session (Liu and
Jernigan, 2011). Moreover, it has been demonstrated that nicotine loco-
motor sensitization was accompanied by downregulation in NPY mRNA
levels in the medial nucleus of amygdala (Aydin et al., 2011).
Overall, pretreatment with cocaine induced sensitized locomo-
tor response to cocaine and nicotine, and escalated of nicotine
self-administration accompanied by enhancement of BDNF expres-
sion in of accumbens neurons.
5. Conclusion
Pretreatment with cocaine caused sensitization of cocaine motor re-
sponse and locomotor cross-sensitization with nicotine. In the self-
administration experiments repeated cocaine administration caused an
increase in the nicotine break point and nicotine intake during a 24 h
binge session.
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